Psyence Biomedical (PBM) EPS (Basic) (2023 - 2025)

Psyence Biomedical (PBM) EPS (Basic) (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn 0.00
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn - 0.00
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn 0.16
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn 4.06
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn -
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn 6.99
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn 0.01
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn 1.55
9 Revolution Medicines 37.15 Bn 37.15 Bn - -2.29
10 Psyence Biomedical 1.72 Mn 1.72 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.01
Sep 30, 2024 0.21
Mar 31, 2023 -2,417.69